Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blake Gilks

Showing results (61-70 of 383) with videos related to

Pageof 39
Sort By:
Human Pathology|November 11, 2003
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancerNikita Makretsov, C Blake Gilks, Andrew J Coldman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2006
Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovaryJung-Hye Choi, C Blake Gilks, Nelly Auersperg, et al.
The American Journal of Surgical Pathology|September 12, 2009
HER2 Intermediate Breast CancersKristin C Jensen, Torsten O Nielsen, C Blake Gilks, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 16, 2021
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classificationAmy Jamieson, Emily F Thompson, Jutta Huvila, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 16, 2004
Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off levelAbdulmohsen Alkushi, Peter Lim, Andrew Coldman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 12, 2016
Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial NeoplasiaMirna B Podoll, Naveena Singh, C Blake Gilks, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 23, 2015
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy StudyTeresa Pérez, Nikita Makrestsov, John Garatt, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 26, 2007
HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical featuresTakayo Ota, C Blake Gilks, Teri Longacre, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumorRola H Ali, Jeffrey D Seidman, Margaret Luk, et al.
Pageof 39

Showing results (61-70 of 383) with videos related to

Sort By:
Pageof 39
Human Pathology|November 11, 2003
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancerNikita Makretsov, C Blake Gilks, Andrew J Coldman, et al.
The Journal of Clinical Endocrinology and Metabolism|September 7, 2006
Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovaryJung-Hye Choi, C Blake Gilks, Nelly Auersperg, et al.
The American Journal of Surgical Pathology|September 12, 2009
HER2 Intermediate Breast CancersKristin C Jensen, Torsten O Nielsen, C Blake Gilks, et al.
The American Journal of Surgical Pathology|June 19, 2013
Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumorW Glenn McCluggage, Naveena Singh, Stefan Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 16, 2021
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classificationAmy Jamieson, Emily F Thompson, Jutta Huvila, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 16, 2004
Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off levelAbdulmohsen Alkushi, Peter Lim, Andrew Coldman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 12, 2016
Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial NeoplasiaMirna B Podoll, Naveena Singh, C Blake Gilks, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 23, 2015
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy StudyTeresa Pérez, Nikita Makrestsov, John Garatt, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|October 26, 2007
HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical featuresTakayo Ota, C Blake Gilks, Teri Longacre, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumorRola H Ali, Jeffrey D Seidman, Margaret Luk, et al.
Pageof 39